Curium-arkiv - BioStock

Curasight presents funding package

Curasight CEO comments on capital raise and milestone

25 June, 2024

Curasight accelerates with rights issue

Curasight to accelerate therapeutic strategy by DKK 51.2 million capital raise

19 February, 2024

Curaight gets milestone payment

Curasight gets first milestone payment from Curium

2 February, 2024

Oncoinvent

Oncoinvent’s CEO: “Radiopharmaceuticals has emerged as the hottest space in oncology”

31 January, 2024

Strong momentum for Curasight in Q2

Curasight hope to build upon strong momentum

30 August, 2023

Curasight secures deal with Curium

Curasight secures global licence agreement for uTRACE in prostate cancer

11 May, 2023